Cargando…

The impact of a rapid molecular identification test on positive blood cultures from critically ill with bacteremia: A pre-post intervention study

OBJECTIVES: Bloodstream infections in critically ill require a speeded-up microbiological diagnosis to improve clinical outcomes. In this pre-post intervention study, we evaluated how a molecular identification test directly performed on positive blood cultures of critically ill improves patient’s t...

Descripción completa

Detalles Bibliográficos
Autores principales: Verroken, Alexia, Despas, Noémie, Rodriguez-Villalobos, Hector, Laterre, Pierre-François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6762135/
https://www.ncbi.nlm.nih.gov/pubmed/31557233
http://dx.doi.org/10.1371/journal.pone.0223122
_version_ 1783454154434281472
author Verroken, Alexia
Despas, Noémie
Rodriguez-Villalobos, Hector
Laterre, Pierre-François
author_facet Verroken, Alexia
Despas, Noémie
Rodriguez-Villalobos, Hector
Laterre, Pierre-François
author_sort Verroken, Alexia
collection PubMed
description OBJECTIVES: Bloodstream infections in critically ill require a speeded-up microbiological diagnosis to improve clinical outcomes. In this pre-post intervention study, we evaluated how a molecular identification test directly performed on positive blood cultures of critically ill improves patient’s therapeutic management. METHODS: All adult patients staying at the intensive care unit (ICU) at the time of positive blood culture detection were study-eligible. In the 8-month pre-intervention period (P0), standard positive blood culture management was performed. In the 10-month intervention period (P1), a BioFire(®) FilmArray(®) blood culture identification (FA-BCID) test (bioMérieux) was additionally performed 24/7 at detection. The evaluated clinical outcome was time to optimal antimicrobial treatment of the bloodstream infection. FA-BCID microbiological test performances were also analysed. RESULTS: 163 positive blood culture episodes were allocated to P0 and 166 to P1. After the withdrawal of episodes in accordance with defined exclusion criteria, outcome analysis was performed on 110 bloodstream infections both in P0 and P1. Time to optimal antimicrobial treatment in P0 was 14h41 compared to 4h39 in P1. FA-BCID test results led to a treatment adjustment in 35/110 (31.8%) P1 episodes including 26 where the adjustment was the optimal antimicrobial treatment. FA-BCID testing identified 96.2% of the on-panel microorganisms thereby covering 85.2% of our ICU-strain epidemiology. Time to identification with FA-BCID testing was calculated at 1h35. Resistance detection was in complete concordance with routine results. Considering 150 FA-BCID tests were initially performed in P1, 4,3 tests were required to have 1 test leading to an improved therapeutic outcome. CONCLUSIONS: FA-BCID testing drastically reduced time to optimal antimicrobial treatment in critically ill with bloodstream infections.
format Online
Article
Text
id pubmed-6762135
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-67621352019-10-13 The impact of a rapid molecular identification test on positive blood cultures from critically ill with bacteremia: A pre-post intervention study Verroken, Alexia Despas, Noémie Rodriguez-Villalobos, Hector Laterre, Pierre-François PLoS One Research Article OBJECTIVES: Bloodstream infections in critically ill require a speeded-up microbiological diagnosis to improve clinical outcomes. In this pre-post intervention study, we evaluated how a molecular identification test directly performed on positive blood cultures of critically ill improves patient’s therapeutic management. METHODS: All adult patients staying at the intensive care unit (ICU) at the time of positive blood culture detection were study-eligible. In the 8-month pre-intervention period (P0), standard positive blood culture management was performed. In the 10-month intervention period (P1), a BioFire(®) FilmArray(®) blood culture identification (FA-BCID) test (bioMérieux) was additionally performed 24/7 at detection. The evaluated clinical outcome was time to optimal antimicrobial treatment of the bloodstream infection. FA-BCID microbiological test performances were also analysed. RESULTS: 163 positive blood culture episodes were allocated to P0 and 166 to P1. After the withdrawal of episodes in accordance with defined exclusion criteria, outcome analysis was performed on 110 bloodstream infections both in P0 and P1. Time to optimal antimicrobial treatment in P0 was 14h41 compared to 4h39 in P1. FA-BCID test results led to a treatment adjustment in 35/110 (31.8%) P1 episodes including 26 where the adjustment was the optimal antimicrobial treatment. FA-BCID testing identified 96.2% of the on-panel microorganisms thereby covering 85.2% of our ICU-strain epidemiology. Time to identification with FA-BCID testing was calculated at 1h35. Resistance detection was in complete concordance with routine results. Considering 150 FA-BCID tests were initially performed in P1, 4,3 tests were required to have 1 test leading to an improved therapeutic outcome. CONCLUSIONS: FA-BCID testing drastically reduced time to optimal antimicrobial treatment in critically ill with bloodstream infections. Public Library of Science 2019-09-26 /pmc/articles/PMC6762135/ /pubmed/31557233 http://dx.doi.org/10.1371/journal.pone.0223122 Text en © 2019 Verroken et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Verroken, Alexia
Despas, Noémie
Rodriguez-Villalobos, Hector
Laterre, Pierre-François
The impact of a rapid molecular identification test on positive blood cultures from critically ill with bacteremia: A pre-post intervention study
title The impact of a rapid molecular identification test on positive blood cultures from critically ill with bacteremia: A pre-post intervention study
title_full The impact of a rapid molecular identification test on positive blood cultures from critically ill with bacteremia: A pre-post intervention study
title_fullStr The impact of a rapid molecular identification test on positive blood cultures from critically ill with bacteremia: A pre-post intervention study
title_full_unstemmed The impact of a rapid molecular identification test on positive blood cultures from critically ill with bacteremia: A pre-post intervention study
title_short The impact of a rapid molecular identification test on positive blood cultures from critically ill with bacteremia: A pre-post intervention study
title_sort impact of a rapid molecular identification test on positive blood cultures from critically ill with bacteremia: a pre-post intervention study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6762135/
https://www.ncbi.nlm.nih.gov/pubmed/31557233
http://dx.doi.org/10.1371/journal.pone.0223122
work_keys_str_mv AT verrokenalexia theimpactofarapidmolecularidentificationtestonpositivebloodculturesfromcriticallyillwithbacteremiaaprepostinterventionstudy
AT despasnoemie theimpactofarapidmolecularidentificationtestonpositivebloodculturesfromcriticallyillwithbacteremiaaprepostinterventionstudy
AT rodriguezvillaloboshector theimpactofarapidmolecularidentificationtestonpositivebloodculturesfromcriticallyillwithbacteremiaaprepostinterventionstudy
AT laterrepierrefrancois theimpactofarapidmolecularidentificationtestonpositivebloodculturesfromcriticallyillwithbacteremiaaprepostinterventionstudy
AT verrokenalexia impactofarapidmolecularidentificationtestonpositivebloodculturesfromcriticallyillwithbacteremiaaprepostinterventionstudy
AT despasnoemie impactofarapidmolecularidentificationtestonpositivebloodculturesfromcriticallyillwithbacteremiaaprepostinterventionstudy
AT rodriguezvillaloboshector impactofarapidmolecularidentificationtestonpositivebloodculturesfromcriticallyillwithbacteremiaaprepostinterventionstudy
AT laterrepierrefrancois impactofarapidmolecularidentificationtestonpositivebloodculturesfromcriticallyillwithbacteremiaaprepostinterventionstudy